Projects (12581)
Cardiff University Schools involved in this Project
Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2 (01/11/2019 - 31/10/2025)
- Hall, Jeremy
Targeting glucose metabolism for the treatment of Birt Hogg Dube Syndrome (01/10/2009 - 30/09/2010)
- Tee, Andrew
Targeting G-quadruplex nucleic acid structures with caffeine gold compounds for cancer treatment (01/10/2016 - 22/12/2017)
- Casini, Angela
Targeting islet-specific CD8 Tcells in Type 1 diabetes (01/06/2015 - 31/01/2019)
- Wong, Susan
Targeting long-term responses to chemotherapy through a novel stem/immune-related vulnerability in triple negative breast cancer (23/03/2023 - 22/03/2026)
- Clarkson, Richard
Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma (01/10/2019 - 30/12/2022)
- Morgan, James
Targeting natural products to counter the challenge of MRSA (01/10/2014 - 30/09/2017)
- Mcguigan, Christopher
Targeting neuroinflammation in mTORC1 driven brain tumours (01/10/2019 - 31/05/2023)
- Tee, Andrew
Targeting NF-xB activation and proliferation signals in CLL (01/11/2013 - 31/07/2018)
- Pepper, Christopher
- Targeting novel anti-complement drugs to the brain for therapy of
dementia. (01/10/2021 - 31/12/2026)- Zelek, Wioleta